Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
30.54
-0.99 (-3.14%)
Last updated: Jun 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Lipoic Acid Series | 374.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Lipoic Acid Series Growth | -17.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Carnosine Series | 59.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Carnosine Series Growth | 13.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Phosphatidylcholine Series | 41.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Phosphatidylcholine Series Growth | 2.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Irecoxib | 6.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Irecoxib Growth | 231.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 6.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | -67.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Granular Lipoic Acid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Granular Lipoic Acid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GPC - Liquid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GPC - Liquid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
L-Carnosine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
L-Carnosine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ethyl Dichlorooctanoate | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ethyl Dichlorooctanoate Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
High Purity Solvent-free Lipoic Acid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
High Purity Solvent-free Lipoic Acid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
R-Lipoic Acid Tromethamine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
R-Lipoic Acid Tromethamine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Others - Lipoic Acid Series | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Others - Lipoic Acid Series Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
R-Lipoic Acid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
R-Lipoic Acid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
API Alpha Lipoic Acid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
API Alpha Lipoic Acid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Abroad | 307.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Abroad Growth | -16.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 181.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -8.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oceania | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oceania Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|